Background Image
Table of Contents Table of Contents
Previous Page  15 / 18 Next Page
Information
Show Menu
Previous Page 15 / 18 Next Page
Page Background

SA JOURNAL OF DIABETES & VASCULAR DISEASE

DRUG TRENDS

VOLUME 18 NUMBER 1 • JULY 2021

13

Dairy-rich diet linked to lower risk of diabetes and

cardiovascular disease

E

ating at least two daily servings of dairy is linked to lower risks

of diabetes and high blood pressure, as well as the cluster of

factors that heighten cardiovascular disease risk (the metabolic

syndrome), finds a large international study, led by Dr Andrew

Mente at the Population Health Research Institute, Hamilton Health

Sciences and McMaster University. The observed associations were

strongest for full-fat dairy products, the findings indicated.

Previously published research has suggested that higher dairy

intake is associated with a lower risk of diabetes, high blood

pressure and the metabolic syndrome. But these studies have

tended to focus on North America and Europe to the exclusion of

other regions of the world.

To see whether these associations might also be found in a

broader range of countries, the researchers drew on people taking

part in the Prospective Urban Rural Epidemiology (PURE) study.

Participants were all aged between 35 and 70 years and came from

21 countries: Argentina, Bangladesh, Brazil, Canada, Chile, China,

Colombia, India, Iran, Malaysia, Palestine, Pakistan, Philippines,

Poland, South Africa, Saudi Arabia, Sweden, Tanzania, Turkey,

United Arab Emirates, and Zimbabwe.

Usual dietary intake over the previous 12 months was assessed

by means of food frequency questionnaires. Dairy products included

milk, yogurt, yogurt drinks, cheese and dishes prepared with dairy

products, and were classified as full or low fat (1–2%).

Butter and cream were assessed separately as these are not

commonly eaten in some of the countries studied.

Information on personal medical history, use of prescription

medicines, educational attainment, smoking and measurements

of weight, height, waist circumference, blood pressure and fasting

blood glucose level were also collected.

Data on all five components of the metabolic syndrome were

available for nearly 113 000 people: blood pressure above 130/85

mm Hg, waist circumference above 80 cm, low levels of (beneficial)

high-density lipoprotein cholesterol (< 1–1.3 mmol/l), blood fats

(triglycerides) of > 1.7 mmol/dl, and fasting blood glucose of 5.5

mmol/l or more.

Average daily total dairy consumption was 179 g, with full fat

accounting for around double the amount of low fat: 124.5+

versus 65 g.

Some 46 667 people had the metabolic syndrome, defined as

having at least three of the five components. Total dairy and full-fat

dairy but not low-fat dairy were associated with a lower prevalence

of most components of the metabolic syndrome, with the size of

the association greatest in those countries with normally low dairy

intakes. At least two servings a day of total dairy were associated

with a 24% lower risk of the metabolic syndrome, rising to 28%

for full-fat dairy alone, compared with no daily dairy intake.

The health of nearly 190 000 participants was tracked for an

average of nine years, during which time 13 640 people developed

high blood pressure and 5 351 developed diabetes.

At least two servings a day of total dairy was associated with an

11–12% lower risk of both conditions, rising to a 13–14% lower

risk for three daily servings. The associations were stronger for full-

fat than they were for low-fat dairy.

This is an observational study, and as such can’t establish cause.

Food frequency questionnaires are also subject to recall, and

changes in the metabolic syndrome were not measured over time,

all of which may have influenced the findings.

Nevertheless, the researchers suggest: ‘If our findings are

confirmed in sufficiently large and long-term trials, then increasing

dairy consumption may represent a feasible and low-cost approach

to reducing (the metabolic syndrome), hypertension, diabetes and

ultimately cardiovascular disease events worldwide.’

Source: MedicalBrief 2020

Drug Trends

SILDENAFIL 50 mg•100 mg

It’s time

we talk

about ED

www.

mydynamics

.co.za

FOR YOUR PATIENTS’

CONVENIENCE

PACKED IN A

DISCREET

PACK SIZE

Give them one

less thing to

stress about.

DYNAFIL 50, 100 mg.

Each tablet contains sildenafil citrate equivalent to 50, 100 mg sildenafil respectively.

S4 A42/7.1.5/1071, 1072. NAM NS2 13/7.1.5/0086, 0087. For full prescribing information, refer to the professional

information approved by SAHPRA, 23 January 2020.

DLC710/04/2021.

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za